CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-07 | Murray Dallan Chief Customer Officer | Option exercise | +5,500 | 33,659 | ||
| 2025-03-07 | Murray Dallan Chief Customer Officer | Option exercise · Performance Stock Units | −5,500 | 0 | ||
| 2025-03-07 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −585 | $103.70 | $61K | 61,871 |
| 2025-03-07 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −9,094 | $103.70 | $943K | 52,777 |
| 2025-03-07 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −514 | $103.70 | $53K | 82,308 |
| 2025-03-07 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −7,990 | $103.70 | $829K | 74,318 |
| 2025-03-07 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −1,131 | $103.70 | $117K | 12,194 |
| 2025-03-07 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −347 | $103.70 | $36K | 11,847 |
| 2025-03-07 | Murray Dallan Chief Customer Officer | Shares withheld for taxes | −549 | $103.70 | $57K | 36,772 |
| 2025-03-07 | Murray Dallan Chief Customer Officer | Shares withheld for taxes | −8,613 | $103.70 | $893K | 28,159 |
| 2025-03-07 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −508 | $103.70 | $53K | 33,274 |
| 2025-03-07 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −8,527 | $103.70 | $884K | 24,747 |
| 2025-03-06 | Estepan Ian Michael Chief Financial Officer | Option exercise | +17,500 | 62,456 | ||
| 2025-03-06 | Estepan Ian Michael Chief Financial Officer | Option exercise · Performance Stock Units | −17,500 | 0 | ||
| 2025-03-06 | Rodino-Klapac Louise Head of R&D, CSO | Option exercise | +17,500 | 82,822 | ||
| 2025-03-06 | Rodino-Klapac Louise Head of R&D, CSO | Option exercise · Performance Stock Units | −17,500 | 0 | ||
| 2025-03-06 | Murray Dallan Chief Customer Officer | Option exercise | +17,500 | 37,321 | ||
| 2025-03-06 | Murray Dallan Chief Customer Officer | Option exercise · Performance Stock Units | −17,500 | 0 | ||
| 2025-03-06 | Arif Bilal Chief Tech Ops Officer | Option exercise | +17,500 | 33,782 | ||
| 2025-03-06 | Arif Bilal Chief Tech Ops Officer | Option exercise · Performance Stock Units | −17,500 | 0 |
Page 7 of 12 · 227 trades